COVID-19 Vaccine

Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases

Technical Competitivity

EES Effectively induce neutralizing antibody and cytotoxic T cell production

Cellid's COVID-19 spike protein design considered elevating structural stability and expression rate.
This gives immune cells enough time to recognize antigens, and as a result, it induces effective antibody production and durable CD8 T cell responses.

Scroll left and right to read.